Kyowa Hakko pulls Japanese filing for sublingual fentanyl
This article was originally published in Scrip
Executive Summary
Kyowa Hakko Kirin has withdrawn an approval filing in Japan for a sublingual tablet formulation of fentanyl citrate for the treatment of breakthrough pain in cancer patients.